Post Categories
Research Reveals How Epidural Electrical Stimulation Helps People Walk Again
April 3, 2023
Building on previous research that showed how epidural electrical stimulation (EES) can help restore walking ability in people with spinal cord injuries, neuroscientists have…
The Gut-Brain Connection in Alzheimer’s Disease
March 27, 2023
Neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease, are often associated with the build-up of cellular debris, like misfolded proteins, within the…
Can We Reverse Aging by Targeting Old Cells?
March 22, 2023
James Kirkland and Tamara Tchkonia, researchers at the Mayo Clinic, are at the forefront of a movement focused on stopping chronic disease by targeting…
Harnessing the Power of Monoclonal Antibodies in the Fight Against Malaria
March 20, 2023
Monoclonal antibodies have been deployed to treat a variety of diseases, from cancer to COVID-19. Now this treatment approach, which doesn’t depend on the…
First Vaccine for Honeybees Prevents American Foulbrood
March 15, 2023
A healthy honeybee population is a critical component of healthy ecosystems, clean air, and stable soil. Honeybees also play a critical role in food…
Precision Steering of CAR-T Therapies May Effectively Target More Tumor Types
March 13, 2023
Recent years have seen increased research interest in the potential of chimeric antigen receptor (CAR)-T cancer therapies. This approach uses genetic engineering to modify…
First Malaria Vaccine Is a Milestone Achievement and Poses a Manufacturing Challenge
March 6, 2023
Following 30 years of research and development, the first malaria vaccine was recommended by the World Health Organization (WHO) for widespread use in children…
Genome Sequencing Labs in Africa and Asia Expand Beyond COVID-19 to Endemic Diseases
February 27, 2023
Funding unlocked during the COVID-19 pandemic allowed many countries in Asia and Africa to perform in-house genome sequencing, resulting in faster results and action…
Flush Analysis Reveals Potentially Harmful Plumes from Powerful Public Toilets
February 20, 2023
Flushing a toilet sends waste and water down, but do you ever wonder about what is sprayed up into the air at the same…
Is Stool Screening an Effective Tool for Preventing Colon Cancer?
February 15, 2023
Colonoscopies have historically been the dominant method of screening for early detection of colon cancer, the third leading cause of cancer death in the…
Research on Extending Lifespan with Cell Reprogramming Yields “Cautious Optimism”
February 13, 2023
Investors are pouring hundreds of millions of dollars into research designed to minimize the harms of aging through genetic engineering. The San Diego-based biotech,…
Experimental mRNA Vaccine Takes a Multivalent Approach to the Flu
February 6, 2023
The events of the COVID-19 pandemic have largely upended how we perceive and respond to global viral threats. One positive change is the technology…
Could Gene Therapy in Cows Slow Climate Change?
October 28, 2024
Despite the impact of companies like Impossible Foods, which markets plant-based imitation meat products, the demand for beef has never been higher. As of…
Weight Loss Drug Prescriptions Become More Accessible With Single-Dose Option
October 21, 2024
Eli Lilly has launched a new way for patients to access its popular weight loss drug, Zepbound® (tirzepatide). The company now offers single-dose vials…
Sizing Up Potential Medicare Costs of Covering Weight Loss Drugs for Heart Health
October 14, 2024
Medicare may soon face steeply increased prescription drug costs as it considers covering the popular weight loss drug, Wegovy® (semaglutide). Known for its ability…
Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso…
Advancing CRISPR-Based Treatment for Rare Swelling Disease
September 30, 2024
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the Phase II clinical trial of NTLA-2002, a CRISPR-based therapy targeting hereditary angioedema (HAE),…
Advancing Phase 3 Trials for ADC Cancer Therapies
September 25, 2024
Antibody-drug conjugates (ADCs) are being studied in various diseases, including cancer, autoimmune and infectious diseases. In cancer, ADCs are made up of a monoclonal…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
GRONINGEN, Netherlands–(BUSINESS WIRE)–QPS Holdings, LLC (QPS) today announced a significant renewal of its elemental bioanalysis infrastructure through the acquisition of two PerkinElmer NexION® 2200…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…